Cardiopulmonary Responses to 6-Minute Stepper Test in Bronchiectasis Versus Healthy Controls
Comparison of Cardiopulmonary Responses to 6-Minute Stepper Test Between Individuals with Bronchiectasis and Healthy Controls
1 other identifier
observational
60
1 country
1
Brief Summary
Individuals with bronchiectasis exhibit productive cough and recurrent lung infections as well as reduced exercise capacity, physical activity level, and respiratory and peripheral muscle strength. 6-minute walk test (6MWT) is often used to assess exercise capacity in chronic lung diseases. 6MWT is recommended to be performed along a flat corridor, at least 30 m long, with low pedestrian traffic, on a hard surface. To overcome technical limitations during 6MWT, 6-minute stepper test (6MST) has been proposed to assess exercise capacity. Another test that provides information about exercise capacity is the 1-minute sit-to-stand test (1STS). To our knowledge, there is limited information about different exercise tests including 6MST and 1STS and cardiopulmonary responses to these tests in individuals with bronchiectasis. Therefore, this study aims to compare the responses to the 6MST between individuals with bronchiectasis and healthy controls and to investigate the relationships among 6MST, 6MWT, and 1STS responses and muscle strength.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 18, 2024
CompletedFirst Submitted
Initial submission to the registry
October 4, 2024
CompletedFirst Posted
Study publicly available on registry
October 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 18, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 18, 2026
CompletedOctober 8, 2024
October 1, 2024
1.3 years
October 4, 2024
October 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Maximal inspiratory pressure
Maximal inspiratory pressure (MIP) and will be measured using aa mouth-piece pressure measurement device. The measurement will be repeated three times so that there will be no difference of 10 cmH₂O or 10%, and the highest value will be used for analysis.
1st day
Maximal expiratory pressure
Maximal expiratory pressure (MEP) and will be measured using a mouth-piece pressure measurement device. The measurement will be repeated three times so that there will be no difference of 10 cmH₂O or 10%, and the highest value will be used for analysis.
1st day
Peripheral muscle strength
Peripheral muscle strength will be assessed using a portable dynamometer. The peripheral muscle strength test will be repeated three times for the right and left sides.
1st day
6-minute stepper test responses
6-minute stepper test will be performed, and the number of repetitions will be recorded. Cardiopulmonary responses before and after 6-minute stepper test will be recorded. 6-minute stepper test will be performed twice with 30 minutes apart.
1st day
1 minute sit-to-stand test responses
1 minute sit-to-stand test will be performed and the repetitions will be recoded. Cardiopulmonary responses will be recorded before and after the test.
1 minute sit-to-stand test will be performed and the repetitions will be recoded. Cardiopulmonary responses will be recorded before and after the test.
6-minute walk test responses
6-minute walk test will be performed, and the distance walked will be recorded. Cardiopulmonary responses before and after 6-minute walk test will be recorded.
1st day
Secondary Outcomes (8)
Dyspnea
1st day
Charlson Comorbidity Index
1st day
Bronchiectasis Severity Index
1st day
Forced vital capacity
1st day
Forced expiratory volume in one second
1st day
- +3 more secondary outcomes
Study Arms (2)
Bronchiectasis
Individuals with bronchiectasis
Healthy controls
Interventions
Eligibility Criteria
Individuals with bronchiectasis and healthy controls
You may qualify if:
- Being 18 years of age and older,
- Having a clinically stable bronchiectasis,
- To cooperate with the tests to be performed,
- Not having a cardiovascular disease, orthopedic or neurological problem that may affect the tests,
- Being willing to participate in the study.
You may not qualify if:
- Being in an acute exacerbation period,
- Having a cardiovascular, orthopedic or neurological problem that may affect the tests,
- Not being willing to participate in the study.
- Being 18 years of age and older,
- To cooperate with the tests to be performed,
- Not having a cardiovascular, orthopedic or neurological problem that may affect the tests,
- Being willing to participate in the study.
- \- Individuals with any known internal disease and those who do not volunteer to participate in the study will not be included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University Faculty of Physical Therapy and Rehabilitation
Ankara, Ankara, 06100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Aslihan Cakmak-Onal Study Principal Investigator, PhD, PT
CONTACT
Elif Kocaaga, MSc, PT
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 4, 2024
First Posted
October 8, 2024
Study Start
September 18, 2024
Primary Completion
January 18, 2026
Study Completion
January 18, 2026
Last Updated
October 8, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share